Corrigendum: Vedolizumab in paediatric inflammatory Bowel Disease: A retrospective multi-centre experience from the paediatric IBD Porto Group of ESPGHAN [Journal of Crohn's and Colitis, 630 (2018)] doi:10.1093/ecco-jcc/jjx172

Oren Ledder, Amit Assa, Arie Levine, Johanna C. Escher, Lissy de Ridder, Frank Ruemmele, Neil Shah, Ron Shaoul, Victorien M. Wolters, Astor Rodrigues, Holm H. Uhlig, Carsten Posovszky, Kaija Leena Kolho, Christian Jakobsen, Shlomi Cohen, Dror S. Shouval, Tim de Meij, Javier Martin-de-Carpi, Lisa Richmond, Jiri BronskyMira Friedman, Dan Turner

Research output: Contribution to journalComment/debate

Abstract

In the original article, author Carsten Posovszky's surname was incorrectly spelt. This has now been corrected.

Original languageAmerican English
Pages (from-to)630
Number of pages1
JournalJournal of Crohn's and Colitis
Volume12
Issue number5
DOIs
StatePublished - 27 Apr 2018

Bibliographical note

Publisher Copyright:
© 2018 European Crohn's and Colitis Organisation (ECCO). Published by Oxford University Press. All rights reserved.

Fingerprint

Dive into the research topics of 'Corrigendum: Vedolizumab in paediatric inflammatory Bowel Disease: A retrospective multi-centre experience from the paediatric IBD Porto Group of ESPGHAN [Journal of Crohn's and Colitis, 630 (2018)] doi:10.1093/ecco-jcc/jjx172'. Together they form a unique fingerprint.

Cite this